Zinc fights diarrhoea in HIV-1-infected children: In-vitro evidence to link clinical data and pathophysiological mechanism

AIDS

Volumn 21, Issue 1, 2007, Pages 108-110

  Canani, Roberto Berni ^a   Ruotolo, Serena ^a   Buccigrossi, Vittoria ^a   Passariello, Annalisa ^a   Porcaro, Francesco ^a   Siani, Maria Concetta ^a   Guarino, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN; ZINC;

ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; PATHOGENESIS; PRIORITY JOURNAL; SUPPLEMENTATION; WORLD HEALTH ORGANIZATION;

CHILD; DIARRHEA; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV-1; HUMANS; INTESTINAL MUCOSA; IONS; MICRONUTRIENTS; ZINC;

EID: 33845509031     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328011849a     Document Type: Article

References (11)

1. Bobat R, Coovadia H, Stephen C, Naidoo KL, McKerrow N, Black RE, Moss WJ. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomized double-blind placebo-controlled trial. Lancet 2005; 366:1862-1867.
2. Bhutta ZA, Bird SM, Black RE, Brown KH, Meeks Gardner J, Hidayat A, et al. Therapeutic effects of oral zinc in acute and persistent diarrhoea in children in developing countries: pooled analysis of randomised controlled trial. Am J Clin Nutr 2000; 72:1516-1522.
3. Brooks WA, Santosham M, Naheed A, Goswami D, Wahed MA, Diener-West M, et al. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomized controlled trial. Lancet 2005; 366:999-1004.
4. Berni Canani R, Ruotolo S. The dawning of the 'zinc era' in the treatment of pediatric acute gastroenteritis worldwide? J Pediatr Gastroenterol Nutr 2006; 42:253-255.
5. Janoff EN, Smith PD. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterology 2001; 120:607-621.
6. Berni Canani R, Cirillo P, Mallardo G, Buccigrossi V, Secondo A, Annunziato L, et al. Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology 2003; 124:368-376.
7. Berni Canani R, De Marco G, Passariello A, Buccigrossi V, Ruotolo S, Bracale I, et al. Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells. AIDS 2006; 20:5-10.
8. Guarino A, Berni Canani R, Casola A, Pozio E, Russo R, Bruzzese E, et al. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis 1995; 171:976-983.
9. Guarino A, Berni Canani R. Enterotoxic and cytotoxic effects of HIV-1 virus in human enterocytes. In: The brush border membrane - from molecular cell biology to clinical pathology. Edited by Naim HY, Zimmer KP. Heilbronn, Germany: SPS Veragsgesellschaft mbH; 2006. pp. 348-360.
10. Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L, et al. The angiogenesis induced by HIV-1 Tat protein is mediated by the flk-1/KDR receptor on vascular endothelial cells. Nat Med 1996; 2:1371-1375.
11. Berni Canani R, Cirillo P, Buccigrossi V, Ruotolo S, Passariello A, De Luca P, et al. Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes. J Infect Dis 2005; 191:1072-1077.